Engineering liposomes for drug delivery: progress and problems
- 1 December 1995
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 13 (12), 527-537
- https://doi.org/10.1016/s0167-7799(00)89017-4
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Combined Vaccines—The European ContributionBiologicals, 1994
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990
- Immunological adjuvants: a role for liposomesImmunology Today, 1990
- How do the polyene macrolide antibiotics affect the cellular membrane properties?Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1986
- Immunoliposomes: Preparation, properties, and applicationsMedicinal Research Reviews, 1986
- The use of monoclonal anti-Thy1IgG1 for the targeting of liposomes to AKR-A cells in vitro and in vivoBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Stability of liposomes invivo and invitro is promoted by their cholesterol content and the presence of blood cellsBiochemical and Biophysical Research Communications, 1979
- Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissuesLife Sciences, 1977
- Homing of liposomes to target cellsBiochemical and Biophysical Research Communications, 1975
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965